Quest Diagnostics (DGX) Net Cash Flow (2009 - 2026)

Quest Diagnostics has reported Net Cash Flow for 18 years, with the latest figure at $234.0 million in Q2 2026.

• Quarterly Net Cash Flow rose 84.25% year-over-year to $234.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $310.0 million (up 520.0% YoY) and the FY2025 annual result came in at -$133.0 million, down 2.31% from the prior year.
• Net Cash Flow grew to $234.0 million in Q2 2026 per DGX's latest filing, from -$26.0 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $543.0 million in Q4 2023 and troughed at -$385.0 million in Q4 2022.
• A 5-year average of -$13.4 million and a median of -$37.5 million in 2023 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow tumbled 322.22% in 2022, then soared 2800.0% in 2024.
• Over 5 years, Net Cash Flow stood at -$385.0 million in 2022, then jumped by 241.04% to $543.0 million in 2023, then plunged by 138.31% to -$208.0 million in 2024, then soared by 93.75% to -$13.0 million in 2025, then jumped by 1900.0% to $234.0 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $234.0 million, -$26.0 million, and -$13.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.